pI: 8.1057 |
Length (AA): 453 |
MW (Da): 49367 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
8 | 84 | 3tht (A) | 282 | 358 | 18.00 | 0.37 | 0.01 | 0.301178 | -0.11 |
110 | 336 | 5cm2 (Z) | 39 | 219 | 33.00 | 0 | 1 | 0.528304 | 0.43 |
133 | 204 | 2nbi (A) | 421 | 495 | 35.00 | 0.097 | 0.05 | 0.35274 | 0.47 |
148 | 196 | 5e24 (E) | 352 | 399 | 12.00 | 0 | 0.01 | 0.305368 | -1.17 |
185 | 318 | 3l8d (A) | 57 | 192 | 16.00 | 0.0000035 | 0.6 | 0.451006 | -0.06 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Bradyzoite. | Gregory Hehl AB Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Oocyst. | Fritz HM |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_127630)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G36310 | S-adenosylmethionine-dependent methyltransferase domain-containing protein |
Babesia bovis | BBOV_I002790 | conserved hypothetical protein |
Brugia malayi | Bm1_17050 | hypothetical protein |
Candida albicans | CaO19.13735 | similar to Diptheria toxin resistance protein |
Candida albicans | CaO19.6378 | similar to Diptheria toxin resistance protein |
Caenorhabditis elegans | CELE_C14B1.10 | Protein ALKB-8 |
Cryptosporidium hominis | Chro.70078 | hypothetical protein |
Cryptosporidium parvum | cgd7_630 | Ym1014wp-like, Ymb4 methylase |
Dictyostelium discoideum | DDB_G0292448 | hypothetical protein |
Drosophila melanogaster | Dmel_CG17807 | CG17807 gene product from transcript CG17807-RA |
Echinococcus granulosus | EgrG_001113800 | alkylated dna repair protein alkb 8 |
Entamoeba histolytica | EHI_031630 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_001113800 | alkylated dna repair protein alkb 8 |
Giardia lamblia | GL50803_7416 | Methyltransferase, putative |
Homo sapiens | ENSG00000137760 | alkB, alkylation repair homolog 8 (E. coli) |
Leishmania braziliensis | LbrM.35.2860 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_362780.1 | methyltransferase domain containing protein, putative |
Leishmania infantum | LinJ.36.2780 | hypothetical protein, conserved |
Leishmania major | LmjF.36.2650 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.2650 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_09472 | hypothetical protein |
Mus musculus | ENSMUSG00000025899 | alkB, alkylation repair homolog 8 (E. coli) |
Neospora caninum | NCLIV_065060 | hypothetical protein, conserved |
Oryza sativa | 4330741 | Os02g0750500 |
Plasmodium berghei | PBANKA_0512100 | methyltransferase, putative |
Plasmodium falciparum | PF3D7_1028000 | methyltransferase, putative |
Plasmodium knowlesi | PKNH_0612400 | methyltransferase, putative |
Plasmodium vivax | PVX_111320 | hypothetical protein, conserved |
Plasmodium yoelii | PY02953 | hypothetical protein |
Saccharomyces cerevisiae | YML014W | Trm9p |
Schistosoma japonicum | Sjp_0000170 | ko:K10770 alkylated DNA repair protein alkB homolog 8, putative |
Schistosoma mansoni | Smp_124160.1 | hypothetical protein |
Schistosoma mansoni | Smp_124160.2 | hypothetical protein |
Schmidtea mediterranea | mk4.007834.04 | Alkylated DNA repair protein alkB homolog 8 |
Schmidtea mediterranea | mk4.011803.00 | Alkylated DNA repair protein alkB homolog 8 |
Trypanosoma brucei gambiense | Tbg972.10.9260 | hypothetical protein, conserved |
Trypanosoma brucei | Tb11.v5.0775 | methyltransferase domain containing protein, putative |
Trypanosoma congolense | TcIL3000_10_6520 | methyltransferase domain containing protein, putative |
Trypanosoma cruzi | TcCLB.510105.150 | methyltransferase domain containing protein, putative |
Trypanosoma cruzi | TcCLB.509715.140 | methyltransferase domain containing protein, putative |
Toxoplasma gondii | TGME49_248960 | methyltransferase domain-containing protein |
Theileria parva | TP01_0568 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_031080 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_123080 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.7560 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.7560 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.7560 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.7560 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0512100 | Plasmodium berghei | Slow | plasmo |
TGME49_248960 this record | Toxoplasma gondii | Essentiality uncertain | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.